1

M.S. Muthu

Self-assembled smart nano medicine for targeted therapy of advanced non-small cell lung cancer

ICMR

21.27 Lakhs

36 Months

2

M.S. Muthu

Defining the AMR burden of antimicrobial manufacturing waste in Puducherry and Chennai

DBT

106.50 Lakhs

36 Months

3

Shreyans Kumar Jain

Exploring Anti-infective Potential of Panchagavya: Metabolomics and Proteomics Approaches

Govt of India.

65.43 Lakhs

2022-2024

4

Deepak Kumar

Bioluminescence based monitoring of tumor progression and treatment by apoptotic pathway

DBT

42.50 Lakhs

2019-2024

5

Rajnish Kumar

Discovery of novel selective inhibitors of choline acetyltransferase: lead optimization and in vivo pharmacokinetic studies

SERB-SRG, India

32.86 Lakhs

Jan, 2022-Dec, 2023

6

Rajnish Kumar

Development of a toolkit for prediction of blood-brain-barrier permeability using deep learning to expedite CNS drug discovery

SERB-MATRICS, India

6.60 Lakhs

Jan, 2022-Dec, 2024

7

Rajnish Kumar & Vinod Tiwari

Development of Novel Therapeutics for the Redemption from Burn and Frostbite Burn Injury Induced Pain in Military Veterans

SERB, India

40.81 Lakhs

Jan, 2021 – Dec, 2023

8

Sairam Krishnamurthy

Pharmacological evaluation of anti-diabetic effects of some natural drugs sponsored by Industry.

Natreon Inc

28.87 Lakhs

2019-2022

9

Sairam Krishnamurthy

Pharmacology of Natural Drugs in Obesity and Eating Disorders” sponsored by Industry.

Natreon Inc

26.54 Lakhs

2018-20222

10

Senthil Raja A

Synthesis and evaluation of diverse n-functionalized hybrids as muti-target directed ligands for neuroprotective and neurorestorative therapies

MoE, STARS

75.30 Lakhs

2020-2024

11

Sushant Kumar Shrivastava

Design and Development of Molecular hybrids in a multifunctional framework for regulating cholinesterases, β-secretase 1, Amyloid β and oxidative stress against Alzheimer’s disease

ICMR

28.87 Lakhs

Dec 2021-Dec. 2024

12

Sushant Kumar Shrivastava

Design and Development of potential multifunctional molecular hybrids for the treatment of Alzheimer’s disease

SERB

28.28 Lakhs

Jan. 2022 Jan. 2025

13

Vinod Tiwari

Development of Novel Therapeutics for the Redemption from Frostbite and Burn Injury-induced Chronic Pain in Military Veterans

SERB, CRG

40.81 Lakhs

2020 - 2023

14

Vinod Tiwari

Development of Transient Receptor Potential Ankyrin-1 (TRPA1) Nociceptor based siRNA Nano-Therapeutics for the Treatment of Chemotherapy-induced Neuropathic Pain

ICMR-SRF

15.21 Lakhs

2020 - 2023

15

Vinod Tiwari

Development of Multifunctional Dendrimer Stabilized Green Nano-Therapeutics for the Treatment of Drugs and Alcohol Addiction

ICMR-SRF

13.20 lakhs

2019 - 2022

16

Dinesh Kumar

Crystal Engineering of Dapagliflozin to improve its ph7armaceutical properties

SERB-DST, India

31.40 Lakhs

2021 - 2023

17

S. K. Mishra

Safety and Efficacy of PL05

Purobien Lifesciences

19.00 Lakhs

2022 - 2023